REQUEST A DEMO
Total
USD $0.00
Search more companies

Maxwell Pharma Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing | Pharmacies and Drug Stores | Management of Companies and Enterprises
Full name: Maxwell Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Manufacture, wholesale and trading of cosmeceutical skin care productsagent for the provision of analytical study services of pharmaceutical related servicesinvestment company

Headquarters
No.23-2, Block B, Zenith Corporate Park,, No.1, Jalan Ss7/26, Kelana Jaya,
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Maxwell Pharma Sdn. Bhd. report to view the information.

Basic Information
Total Employees:
Purchase the Maxwell Pharma Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Maxwell Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Maxwell Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Maxwell Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
June 21, 2000
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
35%
Purchase this report to view the information.
35%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Maxwell Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
16.67%
Total operating revenue
16.67%
Operating profit (EBIT)
34.33%
EBITDA
34.22%
Net Profit (Loss) for the Period
32.42%
Total assets
16.77%
Total equity
22.94%
Operating Profit Margin (ROS)
1.68%
Net Profit Margin
1.19%
Return on Equity (ROE)
1.47%
Debt to Equity Ratio
-3.69%
Quick Ratio
0.47%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?